These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35477449)

  • 1. Online information about mammography screening in Italy from 2014 to 2021.
    Attena F; Abagnale L; Avitabile A
    BMC Womens Health; 2022 Apr; 22(1):132. PubMed ID: 35477449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scarce information about breast cancer screening: An Italian websites analysis.
    Attena F; Cancellieri M; Pelullo CP
    Medicine (Baltimore); 2016 Dec; 95(50):e5615. PubMed ID: 27977602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Content of official addressed to women informative documents about breast cancer screening in Spain].
    Ballesteros-Peña S; Gavilán-Moral E
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30361472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online information about risks and benefits of screening mammography in 10 European countries: An observational Web sites analysis.
    Spagnoli L; Navaro M; Ferrara P; Del Prete V; Attena F;
    Medicine (Baltimore); 2018 Jun; 97(22):e10957. PubMed ID: 29851843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information provided by Italian breast cancer screening programmes: a comparison between 2001 and 2014.
    Castagno R; Canuti D; Petrella M; Bucchi L; Fedato C; Garena F; Giordano L
    Epidemiol Prev; 2015; 39(3 Suppl 1):48-51. PubMed ID: 26405776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
    Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G
    Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of extending screening mammography to older women: Information to support informed choices.
    Jacklyn G; Howard K; Irwig L; Houssami N; Hersch J; Barratt A
    Int J Cancer; 2017 Oct; 141(8):1540-1550. PubMed ID: 28662267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study.
    Tsuruda KM; Veierød MB; Houssami N; Waade GG; Mangerud G; Hofvind S
    BMJ Open; 2021 Dec; 11(12):e052121. PubMed ID: 34907059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
    Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
    Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.